Pulse Biosciences Inc. (PLSE)
NASDAQ: PLSE
· Real-Time Price · USD
16.90
0.04 (0.24%)
At close: May 23, 2025, 3:59 PM
16.89
-0.06%
After-hours: May 23, 2025, 04:04 PM EDT
Pulse Biosciences Revenue Breakdown
| Period Ending | Dec 31, 2022 |
|---|---|
| Cycle Units Products Revenue | 140K |
| Cycle Units Products Revenue Growth | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2022 |
|---|---|
| North America Revenue | 517K |
| North America Revenue Growth | n/a |
| Rest Of World Revenue | 183K |
| Rest Of World Revenue Growth | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 7.73M | 9.6M | 5.95M | 4.23M | 3.58M | 4.43M | 3.78M | 3.53M | 3.73M | 3.35M | 5.11M | 7.48M | 10.04M | 9.36M | 7.66M | 7.35M | 9.46M | 6.17M | 5.77M | 5.32M | 5.6M | 7.17M | 5.61M | 5.15M | 4.4M | 3.81M | 5.67M | 5.17M | 5.38M | 5.8M | 4.16M | 3.77M | 1.22M | 870K | 893K | 642K | 528K | 417.21K | 408K | 243K | 156K |
| Selling, General, and Administrative Revenue Growth | -19.46% | +61.27% | +40.71% | +18.32% | -19.30% | +17.20% | +7.08% | -5.44% | +11.43% | -34.42% | -31.68% | -25.52% | +7.31% | +22.13% | +4.26% | -22.35% | +53.48% | +6.83% | +8.54% | -5.10% | -21.90% | +27.97% | +8.94% | +16.93% | +15.39% | -32.79% | +9.70% | -3.90% | -7.21% | +39.48% | +10.26% | +209.18% | +40.23% | -2.58% | +39.10% | +21.59% | +26.55% | +2.26% | +67.90% | +55.77% | n/a |
| Research and Development Revenue | 10.31M | 10.66M | 7.7M | 7.23M | 6.74M | 7.8M | 7.47M | 6.7M | 5.83M | 4.09M | 4.52M | 5.46M | 6.77M | 5.66M | 6.46M | 7.46M | 9.06M | 7.42M | 6.97M | 5.87M | 6.18M | 6.59M | 6.19M | 6.34M | 5.84M | 5.08M | 5.04M | 3.96M | 3.17M | 2.86M | 3.2M | 2.28M | 1.85M | 1.81M | 1.74M | 1.45M | 990K | 951.34K | 659K | 547K | 421K |
| Research and Development Revenue Growth | -3.27% | +38.41% | +6.54% | +7.25% | -13.57% | +4.38% | +11.57% | +14.89% | +42.34% | -9.34% | -17.24% | -19.37% | +19.64% | -12.41% | -13.39% | -17.70% | +22.06% | +6.56% | +18.71% | -5.03% | -6.21% | +6.43% | -2.29% | +8.47% | +15.00% | +0.83% | +27.22% | +24.72% | +10.86% | -10.50% | +40.23% | +23.28% | +2.49% | +3.85% | +19.68% | +46.77% | +4.06% | +44.36% | +20.48% | +29.93% | n/a |